You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chimeric antigen receptor T-cell therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphomas, B-cell Lymphomas Trial in Houston (JV-213, Leukapheresis)

Not yet recruiting
  • Lymphomas
  • B-cell Lymphomas
  • Houston, Texas
    The University of Texas M D Anderson Cancer Center
Mar 6, 2023

Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

Not yet recruiting
  • Lymphoma
  • +2 more
  • Web Application
  • San Francisco, California
    University of California, San Francisco
Oct 4, 2022

Non-hodgkin Lymphoma, Acute Lymphocytic Leukemia Trial in Saint Louis (Duvelisib)

Recruiting
  • Non-hodgkin Lymphoma
  • Acute Lymphocytic Leukemia
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 30, 2022

Refractory Multiple Myeloma, Relapse Multiple Myeloma Trial in Milwaukee (Belantamab mafodotin)

Recruiting
  • Refractory Multiple Myeloma
  • Relapse Multiple Myeloma
  • Belantamab mafodotin
  • Milwaukee, Wisconsin
    Froedtert & the Medical College of Wisconsin
Aug 3, 2022

Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jul 9, 2022

Advanced Hepatocellular Carcinoma Trial (EU307 CAR-T Cell)

Not yet recruiting
  • Advanced Hepatocellular Carcinoma
  • EU307 CAR-T Cell
  • (no location specified)
Mar 13, 2023

Cardiovascular Events Among Adults Relapsed or Refractory

Recruiting
  • Recurrent Aggressive B-Cell Non-Hodgkin Lymphoma
  • +9 more
  • Electronic Health Record Review
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

CAR-T Treatment for Hematological Malignancies

Recruiting
  • Hematological Malignancies
  • Chimeric Antigen Receptor T-cell Therapy
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Sep 11, 2023

    CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

    Not yet recruiting
    • Lymphoma
    • Chimeric Antigen Receptor
    • (no location specified)
    Oct 24, 2023

    Cytokine Release Syndrome Trial (CTO1681 10 µg, CTO1681 20 µg, CTO1681 30 µg)

    Not yet recruiting
    • Cytokine Release Syndrome
    • CTO1681 10 μg
    • +2 more
    • (no location specified)
    Jun 6, 2023

    Large B-cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Tampa (Comprehensive Ablative Bridging Irradiation (CABI),

    Recruiting
    • Large B-cell Lymphoma
    • Relapsed Non-Hodgkin Lymphoma
    • Comprehensive Ablative Bridging Irradiation (CABI)
    • Chimeric Antigen Receptor T-Cell Therapy
    • Tampa, Florida
      Moffitt Cancer Center
    Oct 26, 2023

    Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

    Not yet recruiting
    • Chronic Graft Versus Host Disease
    • +2 more
    • Biopsy
    • +11 more
    • Duarte, California
      City of Hope Medical Center
    Aug 7, 2023

    Malignant Tumor, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the Leptomeninges Trial in Duarte

    Recruiting
    • Malignant Neoplasm
    • +4 more
    • Chimeric Antigen Receptor T-Cell Therapy
    • Duarte, California
      City of Hope Medical Center
    Sep 14, 2022

    Digestive Tumor Trial (TM4SF1-positive chimeric antigen receptor T-cell therapy)

    Not yet recruiting
    • Digestive Tumor
    • TM4SF1-positive chimeric antigen receptor T-cell therapy
    • (no location specified)
    Dec 21, 2022

    Recurrent DLBCL, Refractory DLBCL Trial in Duarte (procedure, biological, radiation)

    Not yet recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • Refractory Diffuse Large B-Cell Lymphoma
    • Biospecimen Collection
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Mar 24, 2023

    Kidney Transplant, Kidney Failure, Highly Sensitized Trial in Boston, New York, Philadelphia (Cyclophosphamide, CART-BCMA,

    Not yet recruiting
    • Kidney Transplant
    • +2 more
    • Boston, Massachusetts
    • +2 more
    Sep 20, 2023

    Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

    Not yet recruiting
    • Multiple Sclerosis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Palo Alto, California
      Stanford Multiple Sclerosis Center
    Nov 13, 2023

    Lupus Nephritis, Lupus Nephritis - World Health Organization (WHO) Class III, Lupus Nephritis - WHO Class IV Trial in Denver,

    Recruiting
    • Lupus Nephritis
    • +2 more
    • KYV-101 anti-CD19 CAR-T cell therapy
    • Standard lymphodepletion regimen
    • Denver, Colorado
    • +1 more
    Jul 7, 2023

    Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

    Not yet recruiting
    • Neuroendocrine Tumor (NET)
    • Colorectal Cancer (CRC)
    • CHM-2101 CAR-T cells
    • (no location specified)
    Sep 20, 2023

    Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy

    Recruiting
    • DLBCL
    • +8 more
    • Cardiac MRI
    • Bonn, NRW, Germany
      University Hospital Bonn
    Jun 11, 2022

    Refractory Non-Hodgkin Lymphoma, Relapsed Non Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma Trial in Miami (Mosunetuzumab,

    Not yet recruiting
    • Refractory Non-Hodgkin Lymphoma
    • +2 more
    • Miami, Florida
      University of Miami
    Aug 3, 2022

    Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Chapel Hill (Nivolumab, Pembrolizumab)

    Recruiting
    • Relapsed Hodgkin Lymphoma
    • Refractory Hodgkin Lymphoma
    • Nivolumab
    • Pembrolizumab
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Jul 22, 2022

    Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

    Not yet recruiting
    • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
    • +5 more
    • Boston, Massachusetts
    • +1 more
    Jun 28, 2023

    Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited Trial in Zhengzhou (ThisCART19A, Fludarabine Pill, Cyclophosphamide)

    Not yet recruiting
    • Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
    • Zhengzhou, Henan, China
      Henan cancer hospital
    Nov 28, 2022

    Multiple Myeloma Trial in New York (Ide-cel (bb2121))

    Recruiting
    • Multiple Myeloma
    • Ide-cel (bb2121)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jul 6, 2022